Northwest Biotherapeutics, Inc.

The current price of NWBO is 0.4800 USD — it has decreased by 5.88% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Northwest Biotherapeutics, Inc. stocks are traded under the ticker NWBO.

Northwest Biotherapeutics, Inc. is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.

NWBO stock is 8.33% volatile and has beta coefficient of −1.45. Check out the list of the most volatile stocks — is Northwest Biotherapeutics, Inc. there?

Yes, you can track Northwest Biotherapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

NWBO stock has fallen by 10.45% compared to the previous week, the month change is a 5.88% fall, over the last year Northwest Biotherapeutics, Inc. has showed a 9.43% decrease.

Today Northwest Biotherapeutics, Inc. has the market capitalization of ‪606.89 M‬, it has decreased by 1.86% over the last week.

No, NWBO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, NWBO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Northwest Biotherapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

NWBO reached its all-time high on Jan 8, 2002 with the price of 1420.8000 USD, and its all-time low was 0.1400 USD and was reached on Apr 25, 2017.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has 22.00 employees. See our rating of the largest employees — is Northwest Biotherapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Northwest Biotherapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Northwest Biotherapeutics, Inc. stock shows the strong sell signal. See more of Northwest Biotherapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Northwest Biotherapeutics, Inc. EBITDA is ‪−53.78 M‬ USD, and current EBITDA margin is ‪−2.78 K‬%. See more stats in Northwest Biotherapeutics, Inc. financial statements.